"Severe neutropenia occurs in a small percentage of patients taking clozapine; however, neutropenia is associated with an ...
With the failure of AbbVie’s emraclidine in two mid-stage trials, Bristol Myers Squibb’s Cobenfy is 'sole muscarinic winner.' ...
Fampridine, used for improving walking in multiple sclerosis, may also enhance working memory in individuals with schizophrenia or depression.
Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in mental health conditions ...
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
4don MSNOpinion
The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...
Ottawa Citizen on MSN6d
Study finds 'concerning link' between hospital visits for psychedelic use and schizophreniaThe research, led by Dr. Daniel Myran, a Canada Research Chair in Social Accountability at the University of Ottawa, followed ...
Keith Murphy discusses his project that uses brain organoids the explore the effect of cocaine exposure in utero.
No approved drug in the U.S. has been able to fully address these symptoms. While second generation antipsychotics offer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback